Paper23902256
Class D β-lactamases: a reappraisal after five decades.
Leonard DA and 2 others. Acc Chem Res, 2013. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Class D β-lactamases: a reappraisal after five decades. Papers, record 23902256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23902256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gram-Negative Bacteria | Major topic |
| beta-Lactamases | Major topic |
| Catalysis | |
| Catalytic Domain | |
| Models, Molecular |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R15AI094489 | NIAID NIH HHS | United States | R15AI094489 | PubMed and NIH | NIH RePORTER |
| R15 AI094489 | NIAID NIH HHS | United States | R15AI094489 | PubMed and NIH | NIH RePORTER |
| R01 AI072219 | NIAID NIH HHS | United States | R01AI072219 | PubMed and NIH | NIH RePORTER |
| R01AI063517 | NIAID NIH HHS | United States | R01AI063517 | PubMed and NIH | NIH RePORTER |
| R15 AI082416 | NIAID NIH HHS | United States | R15AI082416 | PubMed and NIH | NIH RePORTER |
| R01AI072219 | NIAID NIH HHS | United States | R01AI072219 | PubMed and NIH | NIH RePORTER |
| R15AI082416 | NIAID NIH HHS | United States | R15AI082416 | PubMed and NIH | NIH RePORTER |
| R01 AI063517 | NIAID NIH HHS | United States | R01AI063517 | PubMed and NIH | NIH RePORTER |
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9485412 | Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases. | Biochemistry | 1998 | https://conductscience.org/library/papers/9485412 | PubMed |
| 2 | 11132946 | 6-(hydroxyalkyl)penicillanates as probes for mechanisms of beta-lactamases. | J Antibiot (Tokyo) | 2000 | https://conductscience.org/library/papers/11132946 | PubMed |
| 3 | 8830026 | Transferable imipenem-resistance in Acinetobacter species from a clinical source. | J Antimicrob Chemother | 1995 | https://conductscience.org/library/papers/8830026 | PubMed |
| 4 | 23070171 | Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23070171 | PubMed |
| 5 | 10223588 | Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa. | J Antimicrob Chemother | 1999 | https://conductscience.org/library/papers/10223588 | PubMed |
| 6 | 19251630 | Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. | Science | 2009 | https://conductscience.org/library/papers/19251630 | PubMed |
| 7 | 9449253 | Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9449253 | PubMed |
| 8 | 22429123 | Site-saturation mutagenesis of position V117 in OXA-1 β-lactamase: effect of side chain polarity on enzyme carboxylation and substrate turnover. | Biochemistry | 2012 | https://conductscience.org/library/papers/22429123 | PubMed |
| 9 | 17374723 | Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17374723 | PubMed |
| 10 | 20695527 | Reversible post-translational carboxylation modulates the enzymatic activity of N-acetyl-L-ornithine transcarbamylase. | Biochemistry | 2010 | https://conductscience.org/library/papers/20695527 | PubMed |
| 11 | 17000742 | Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/17000742 | PubMed |
| 12 | 21215758 | Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem. | J Mol Biol | 2011 | https://conductscience.org/library/papers/21215758 | PubMed |
| 13 | 19721065 | Diversity, epidemiology, and genetics of class D beta-lactamases. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/19721065 | PubMed |
| 14 | 20822105 | Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase. | J Am Chem Soc | 2010 | https://conductscience.org/library/papers/20822105 | PubMed |
| 15 | 19485421 | Mutation of the active site carboxy-lysine (K70) of OXA-1 beta-lactamase results in a deacylation-deficient enzyme. | Biochemistry | 2009 | https://conductscience.org/library/papers/19485421 | PubMed |
| 16 | 14596597 | Crystal structure of the sensor domain of the BlaR penicillin receptor from Bacillus licheniformis. | Biochemistry | 2003 | https://conductscience.org/library/papers/14596597 | PubMed |
| 17 | 11498375 | b-Lactamase inhibitors. | Drug Resist Updat | 2000 | https://conductscience.org/library/papers/11498375 | PubMed |
| 18 | 18955486 | Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone. | J Biol Chem | 2009 | https://conductscience.org/library/papers/18955486 | PubMed |
| 19 | 21664132 | Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21664132 | PubMed |
| 20 | 11724923 | Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11724923 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42975168 | Structure and Dynamics of Burkholderia pseudomallei OXA-57, a Distinctive Low-Efficiency Class D β-Lactamase with Carbapenem-Hydrolyzing Activity. | Biochemistry | 2026 | https://conductscience.org/library/papers/42975168 | PubMed |
| 42311063 | The Novel Carbapenem, JDB/PQ-1-219, Has Potent Broad Spectrum Activity against Multi-Drug Resistant Acinetobacter baumannii. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/42311063 | PubMed |
| 41240213 | Exploration of novel β-lactamase inhibitors against Klebsiella pneumoniae using fragment-based drug discovery approach. | Mol Divers | 2026 | https://conductscience.org/library/papers/41240213 | PubMed |
| 40919997 | Proteus spp.-taxonomy, clinical significance, and antibiotic resistance of a highly versatile pathogen. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/40919997 | PubMed |
| 40872271 | Diversity in the Common Fold: Structural Insights into Class D β-Lactamases from Gram-Negative Pathogens. | Pathogens | 2025 | https://conductscience.org/library/papers/40872271 | PubMed |
| 40871555 | Avibactam-Cyclodextrin Inclusion Complexes: Computational and Thermodynamic Insights for Drug Delivery, Detection, and Environmental Scavenging. | Molecules | 2025 | https://conductscience.org/library/papers/40871555 | PubMed |
| 40549295 | Pangenome-based network analysis of Acinetobacter baumannii reveals the landscape of conserved therapeutic targets. | Mol Divers | 2026 | https://conductscience.org/library/papers/40549295 | PubMed |
| 40094886 | Standardized Residue Numbering and Secondary Structure Nomenclature in the Class D β-Lactamases. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/40094886 | PubMed |
| 39704504 | Genetic profiling of multidrug-resistant Acinetobacter baumannii from a tertiary care center in Malaysia. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/39704504 | PubMed |
| 39670715 | OXA β-lactamases from Acinetobacter spp. are membrane bound and secreted into outer membrane vesicles. | mBio | 2025 | https://conductscience.org/library/papers/39670715 | PubMed |
| 38534695 | Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38534695 | PubMed |
| 37353133 | The Fe and Zn cofactor dilemma. | Biochim Biophys Acta Proteins Proteom | 2023 | https://conductscience.org/library/papers/37353133 | PubMed |
| 36648230 | Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/36648230 | PubMed |
| 35758005 | A review on the mechanistic details of OXA enzymes of ESKAPE pathogens. | Pathog Glob Health | 2023 | https://conductscience.org/library/papers/35758005 | PubMed |
| 35669117 | Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35669117 | PubMed |
| 35415828 | Metagenomic insights into the microbial community structure and resistomes of a tropical agricultural soil persistently inundated with pesticide and animal manure use. | Folia Microbiol (Praha) | 2022 | https://conductscience.org/library/papers/35415828 | PubMed |
| 35171032 | Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35171032 | PubMed |
| 34943751 | Investigating the OXA Variants of ESKAPE Pathogens. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943751 | PubMed |
| 34817169 | Unique Diacidic Fragments Inhibit the OXA-48 Carbapenemase and Enhance the Killing of Escherichia coli Producing OXA-48. | ACS Infect Dis | 2021 | https://conductscience.org/library/papers/34817169 | PubMed |
| 34778765 | β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates. | RSC Med Chem | 2021 | https://conductscience.org/library/papers/34778765 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23902256
GET https://conductscience.org/api/papers/v1/23902256/references?page=2